{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:09:59Z","timestamp":1790719799412,"version":"4.1.0"},"reference-count":37,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is highly prevalent globally and includes chronic liver diseases ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). The neutrophil-to-albumin ratio (NPAR) is a cost-effective, readily available biomarker of inflammation used to assess cancer and cardiovascular disease prognosis, and it may be of predictive value in NAFLD. This study was to evaluate the associations between the NPAR, the neutrophil-to-lymphocyte ratio (NLR), and the presence of NAFLD or advanced liver fibrosis, and to assess the predictive value of the NPAR in NAFLD in a nationally representative database. This population-based, cross-sectional, retrospective study analyzed the secondary data of adults with NAFLD or advanced liver fibrosis extracted from the National Health and Nutrition Examination Survey (NHANES) database 2017\u20132018. NHANES participants with complete information of vibration-controlled transient elastography (VCTE) and controlled attenuation parameter (CAP) were enrolled. A logistic regression analysis was used to determine the associations between the variables in the participants with and without NAFLD or advanced liver fibrosis. The mean values of the lymphocyte counts, neutrophil counts, NPAR, aspartate aminotransaminase (AST), alanine aminotransaminase (ALT), total cholesterol, triglycerides, and HbA1c were significantly higher in the participants with NAFLD than in those without NAFLD or advanced liver fibrosis. The mean blood albumin levels of the subjects without NAFLD or advancing fibrosis were considerably greater than those of the individuals with these conditions. The mean values of the NLR, NPAR, AST, ALT, triglycerides, lymphocyte count, neutrophil count, and HbA1c were significantly higher in patients with advanced fibrosis than in those without advanced fibrosis. A multivariate analysis showed that per unit increases in both the NLR and NPAR were significantly associated with an increased risk of developing NAFLD, while neither the NLR nor NPAR was significantly associated with higher odds of advanced fibrosis. In conclusion, the novel biomarker NPAR demonstrates a good association with NAFLD, along with participants\u2019 clinical characteristics, in a nationwide population. The NPAR may serve as a biomarker for NAFLD and help clinicians refine the diagnosis and treatment of chronic liver disease.<\/jats:p>","DOI":"10.3390\/nu15081892","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T04:54:24Z","timestamp":1681448064000},"page":"1892","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017\u20132018"],"prefix":"10.3390","volume":"15","author":[{"given":"Chi-Feng","family":"Liu","sequence":"first","affiliation":[{"name":"School of Nursing, National Taipei University of Nursing and Health Science, Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Chien","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 112, Taiwan"},{"name":"Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2012","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.30254","article-title":"Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: A systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.14218\/JCTH.2020.00065","article-title":"Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease","volume":"8","author":"Altajar","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbcan.2018.11.005","article-title":"Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans","volume":"1871","author":"Chen","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1016\/S1470-2045(22)00265-0","article-title":"Clinical features and outcomes of NAFLD-related hepatocellular carcinoma\u2014Authors\u2019 reply","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.14309\/ajg.0000000000000058","article-title":"Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients","volume":"114","author":"Cheung","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Elinav","year":"2012","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7869\/tg.120","article-title":"Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis","volume":"34","author":"Amarapurkar","year":"2013","journal-title":"Trop. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MEG.0b013e32835c2af3","article-title":"Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis","volume":"25","author":"Biyik","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/17474124.2018.1463158","article-title":"The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: A systematic review","volume":"12","author":"Peng","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8137576","DOI":"10.1155\/2020\/8137576","article-title":"Association between Neutrophil Percentage-to-Albumin Ratio and All-Cause Mortality in Critically Ill Patients with Coronary Artery Disease","volume":"2020","author":"Sun","year":"2020","journal-title":"Biomed Res. Int."},{"key":"ref_17","first-page":"5687672","article-title":"The Neutrophil Percentage-to-Albumin Ratio Is Associated with All-Cause Mortality in Critically Ill Patients with Acute Kidney Injury","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res. Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"FSO709","DOI":"10.2144\/fsoa-2021-0008","article-title":"Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy","volume":"7","author":"Ferro","year":"2021","journal-title":"Futur. Sci. OA"},{"key":"ref_19","unstructured":"Zipf, G., Chiappa, M., Porter, K.S., Ostchega, Y., Lewis, B.G., and Dostal, J. (2013). National Health and Nutrition Examination Survey: Plan and Operations, 1999\u20132010."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Pu, K., Wang, Y., Bai, S., Wei, H., Zhou, Y., Fan, J., and Qiao, L. (2019). Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: A systematic review and meta-analysis. BMC Gastroenterol., 19.","DOI":"10.1186\/s12876-019-0961-9"},{"key":"ref_21","first-page":"242","article-title":"Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"7","author":"Hashemi","year":"2016","journal-title":"Casp. J. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/13557858.2022.2027883","article-title":"Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic\/Latinos adults in the U.S","volume":"28","author":"Heredia","year":"2022","journal-title":"Ethn. Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.30825","article-title":"Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV\/HIV Co-infected Adults","volume":"71","author":"Sterling","year":"2019","journal-title":"Hepatology"},{"key":"ref_24","first-page":"585","article-title":"Diagnosis and classification of diabetes mellitus: Highlights from the American Diabetes Association","volume":"42","author":"Rayburn","year":"1997","journal-title":"J. Reprod. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","article-title":"Albumin in chronic liver disease: Structure, functions and therapeutic implications","volume":"10","author":"Spinella","year":"2015","journal-title":"Hepatol. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27322","article-title":"Posttranscriptional changes of serum albumin: Clinical and prognostic significance in hospitalized patients with cirrhosis","volume":"60","author":"Domenicali","year":"2014","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jso.25209","article-title":"NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer","volume":"118","author":"Tingle","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1017\/S0950268820000771","article-title":"Increased neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock","volume":"148","author":"Gong","year":"2020","journal-title":"Epidemiology Infect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2147\/JIR.S394536","article-title":"The Neutrophil Percentage-to-Albumin Ratio is Associated with All-Cause Mortality in Patients with Atrial Fibrillation: A Retrospective Study","volume":"16","author":"Xu","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MEG.0000000000002470","article-title":"Higher levels of neutrophil percentage-to-albumin ratio predict increased mortality risk in patients with liver cirrhosis: A retrospective cohort study","volume":"35","author":"Du","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/endrev\/bnz009","article-title":"Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management","volume":"41","author":"Marjot","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MEG.0000000000000486","article-title":"A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: Multicentric study","volume":"28","author":"Mousa","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1002\/cam4.5185","article-title":"Neutrophil-lymphocyte ratio in relation to risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease","volume":"12","author":"Thomas","year":"2022","journal-title":"Cancer Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/MEG.0000000000002439","article-title":"The correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with nonalcoholic fatty liver disease: A cross-sectional study","volume":"34","author":"Zhou","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/DMSO.S330526","article-title":"Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP)","volume":"15","author":"Lesmana","year":"2022","journal-title":"Diabetes Metab. Syndr. Obesity Targets Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e002243","DOI":"10.1136\/bmjdrc-2021-002243","article-title":"Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes","volume":"9","author":"Loosen","year":"2021","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e062188","DOI":"10.1136\/bmjopen-2022-062188","article-title":"Low-grade inflammation in type 2 diabetes: A cross-sectional study from a Danish diabetes outpatient clinic","volume":"12","author":"Okdahl","year":"2022","journal-title":"BMJ Open"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/8\/1892\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:15:42Z","timestamp":1760123742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/8\/1892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["nu15081892"],"URL":"https:\/\/doi.org\/10.3390\/nu15081892","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}